Ping An Biomedical (PASW) Current Deferred Revenue (2024 - 2025)
Ping An Biomedical's (PASW) quarterly Current Deferred Revenue came in at $9749.0 in Q3 2025, down 95.82% YoY from $233500.2 in Q3 2024, and down 90.66% on a QoQ basis from $104412.0 in Q1 2025.
Ping An Biomedical (PASW) Current Deferred Revenue (2024 - 2025) Analysis & Trends
Ping An Biomedical (PASW) has 2 years of Current Deferred Revenue data on file, last reported at $9749.0 in Q3 2025.
- Quarterly Current Deferred Revenue fell 95.82% year-over-year to $9749.0 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $9749.0 (down 95.82% YoY) and the FY2025 annual result came in at $9801.0, down 95.8% from the prior year.
- Current Deferred Revenue declined to $9749.0 in Q3 2025, from $104412.0 in the prior quarter.
- In the past five years, Current Deferred Revenue ranged from a high of $233500.2 in Q3 2024 to a low of $9749.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Albany International | 1.67 Bn | 1.59 Bn | 107.90 Mn |
| 2 | SMJ International Holdings | 291.52 Mn | 271.89 Mn | - |
| 3 | Unifi | 140.50 Mn | 112.02 Mn | 9.12 Mn |
| 4 | Culp | 41.62 Mn | 41.62 Mn | - |
| 5 | Ping An Biomedical | 2.49 Mn | -2.63 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 9,748.96 |
| Mar 31, 2025 | 104,412.00 |
| Sep 30, 2024 | 233,500.24 |